DAL stock rises as second-quarter earnings and revenues beat estimates and the airline reinstates full-year 2025 guidance.

DAL stock rises as second-quarter earnings and revenues beat estimates and the airline reinstates full-year 2025 guidance.

AngioDynamics beats fourth-quarter fiscal 2025 estimates with strong Med Tech growth amid margin declines and a wider fiscal 2026 loss outlook.

AngioDynamics beats fourth-quarter fiscal 2025 estimates with strong Med Tech growth amid margin declines and a wider fiscal 2026 loss outlook.

DPZ stock jumps after second-quarter revenues beat despite an earnings miss, boosted by store growth and aggregator expansion.

DPZ stock jumps after second-quarter revenues beat despite an earnings miss, boosted by store growth and aggregator expansion.

BMI's Q2 results may reflect strong utility demand and smart tech growth, despite tougher comps and macro headwinds.

LEVI tops second-quarter fiscal 2025 estimates with rising EPS and sales, fueled by strong DTC gains and momentum in global comps.

PGR's second-quarter 2025 results reflect a year-over-year improvement in premiums and net realized gain on securities.

MSCI posts strong second-quarter 2025 earnings and revenue growth, but shares slip despite higher recurring and asset-based fees.